Skip to main content
SP5007,728.46-0.03%DOW53,618.38+0.09%NASDAQ26,490.63-0.19%BTC$77,926.00-3.08%ETH$2,450.18-2.89%GOLD$4,569.50-2.03%OIL$83.03-0.60%
Smart Investors Daily
Sign InSign Up Free
TO

NASDAQ · TOI

The Oncology Institute, Inc.

Healthcare · Medical - Care Facilities

$5.13

Down-$1.26 (-19.72%)

Updated Aug 28, 2026, 4:04 PM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
370.41M
P/E ratio
-55.37
Dividend yield
0.00%
52-week range
$2.57 – $6.67
Volume
1.27M
Avg. volume
2.3M

Price performance

TOI price history

1M range · 3 trading sessions · Daily adjusted prices

TOI closed at $5.13 after 3 trading sessions, up 1.18% for the selected period.

Last close
$5.13
Period change
+1.18%
Period low
$4.86
Period high
$5.13
Daily close
View OHLC price history
TOI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 3, 2026$4.935$5.15$4.87$5.131.27M
Jul 31, 2026$5.10$5.25$4.86$4.861.01M
Jul 30, 2026$4.84$5.175$4.80$5.071.24M

Latest TOI news

The latest Smart Investors Daily articles mentioning TOI.

Stock researchCompany · Overview

TOI research

Overview

Company profile and research snapshot.

Company profile

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$5.00
Implied upside
—
Analysts
—
TOI recent ratings
DateFirmRatingTarget
Jul 9, 2026BTIGBuy—
Jul 6, 2026Lake StreetBuy—
Jun 17, 2026NeedhamBuy—
Jun 8, 2026BTIGBuy—
Mar 13, 2026B. Riley SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 12, 2026

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary 2026 outlook. 2026 Outlook For 2026, TOI anticipates that total revenue will be in the range of $630 million to $650 million, reflecting 28% growth from the midpoint of 2025 and 2026 guidance ranges, and including approximately $150 million of Capita

Yahoo · Jan 9, 2026

U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care

DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or the “Company”), a physician services organization dedicated to transforming community-based neurology care. Through this partnership, USNA will serve neurology practices and their patients across a broad spectrum of neurological indications. Nitin Jain will serve as USNA’s Chief Executive Officer and Br

Yahoo · Jan 9, 2026

Is Oncology Institute (TOI) Quietly Rewiring Its Edge Around AI Talent And Boardroom Financial Discipline?

The Oncology Institute, Inc. recently promoted long-time technology leader Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer, while also adding RadNet CFO Mark Stolper to its Board of Directors. These leadership moves highlight a growing emphasis on AI-enabled technology, data privacy, and talent management, combined with additional healthcare finance expertise at the board level. We’ll now explore how the CIO’s AI-focused mandate and the new board...

Yahoo · Jan 9, 2026

The Oncology Institute Announces Leadership Promotions

Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced today the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. These promotions reinforce TOI’s continued focus on leading the way in value-based cancer care through further development of our technology-enabled care delivery platform as well as strengthe

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By